Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Filings indexed 422 across all filing types
Latest filing 2025-03-12 Audit Report / Informat…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Handok Inc. (주식회사 한독) for the fiscal year ending December 31, 2024. It includes the independent auditor's report from Samjong KPMG, detailed financial statements (Balance Sheet, Income Statement, Statement of Comprehensive Income, Statement of Changes in Equity, Cash Flow Statement), and extensive notes to the financial statements. While it contains financial data, it is specifically the formal audit report required by regulatory standards, not a standalone annual report (10-K) or a simple earnings release. Therefore, it is classified as an Audit Report. FY 2024
2025-03-12 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled '감사보고서 제출' (Submission of Audit Report) filed with the Korean Exchange (KRX). It provides a summary of the audit opinion (which is 'unqualified' or 'proper') and key financial highlights from the consolidated and separate financial statements for the fiscal year ending 2024-12-31. According to the 'Menu vs Meal' rule, this is a short regulatory announcement (under 5,000 characters) notifying the market that the audit report has been submitted and is available, rather than the full audit report document itself. Therefore, it is classified as a Report Publication Announcement (RPA). FY 2024
2025-03-11 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) which includes a correction (정정신고) regarding the agenda items. This document provides the date, location, and specific agenda items (such as director appointments, dividend reporting, and business division plans) for an upcoming Annual General Meeting. In the context of shareholder communications and proxy materials, this document serves as the official notice and information statement provided to shareholders to inform them of the meeting and the matters to be voted upon. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2025-03-11 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Handok Inc. It contains the meeting agenda, details on voting rights, director nominations, and management reports. While it includes some financial information, it is primarily a proxy statement/notice for shareholders to attend the AGM. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category, as it serves to inform shareholders and request their participation/votes for the upcoming meeting.
2025-03-11 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange by Handok Inc. It details the issuance of stock options to employees, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital structure changes and equity-based compensation is classified as a regulatory filing related to share issuance/capital changes.
2025-03-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of recipients and the total number of shares granted due to cancellations. In the context of financial filings, reports concerning the issuance or modification of stock options, especially those involving capital structure changes or employee compensation schemes, are classified under 'Share Issue/Capital Change' (SHA) as they represent a change in the company's potential equity and capital structure.
2025-03-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.